Clinical Trials Directory

Trials / Terminated

TerminatedNCT04453553

CICERO- A Care Home Study of COVID-19

COVID-19 in Vitro Diagnostic Near-patient Testing in Care Environments Using a Cluster Randomised Open-label Trial Design in an East London Care Home Population

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
461 (actual)
Sponsor
Queen Mary University of London · Academic / Other
Sex
All
Age
18 Years – 130 Years
Healthy volunteers
Accepted

Summary

The primary objective of the study is to determine whether, at 21 days, care homes that implemented near-patient daily testing have a lower rate of confirmed CoV-2 infections than care homes following the DHSC standard of care testing of symptomatic residents.

Detailed description

Accurate, rapid, near-patient testing systems, such as q16+CoV-2, allow for daily routine testing of residents, and of staff and visitors prior to entering the care home. Daily CoV-2 PCR testing with high analytical sensitivity (e.g., 2 copies per 8 µl sample) may detect infected residents and visitors before clinical symptoms are apparent. Earlier detection may lead to earlier implementation of the UK standard of care protocol for Infection prevention and control measures, thereby preventing the asymptomatic infected individuals from introducing and/or transmitting CoV-2 within the care home. This should reduce the transmission by: Preventing the introduction of the virus into care homes from external visitors e.g., GPs (Inward transmission) Preventing the spread of the virus within care homes and preventing cluster development (internal transmission) Preventing the outward spread of the virus from within care homes by infection of external visitors (Outward transmission)

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTQ16 testingNasal swab tested on a rapid near patient device
DIAGNOSTIC_TESTNasopharyngeal swab and main laboratoryStandard of care testing

Timeline

Start date
2020-07-02
Primary completion
2020-10-27
Completion
2020-10-27
First posted
2020-07-01
Last updated
2023-08-02

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04453553. Inclusion in this directory is not an endorsement.